Company Overview of CellMed AG
CellMed AG operates as a biotech company. The company focuses on its own therapeutic drug development. It develops bead product for cosmetic dermatology; and drug-eluting bead product for the treatment of stroke, based on proprietary stem cell. CellMed AG offers CellBeads, micro-implants, which produce proteins in the human body; and contain living cells that deliver therapeutic molecules to treat certain diseases. The company was founded in 2000, and is based in Alzenau, Germany. As of March 7, 2005, CellMed AG operates as a subsidiary of Biocompatibles International Ltd.
Founded in 2000
49 6023 9181 0
49 6023 9181 33
Key Executives for CellMed AG
CellMed AG Key Developments
Similar Private Companies By Industry
|4 Animals AlsterScience GmbH||Europe|
|Acousia Therapeutics GmbH||Europe|
|Across Barriers GmbH||Europe|
|Actinodrug Pharmaceuticals GmbH||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact CellMed AG, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.